News
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
Organisers of July’s edition of iGB L!VE – the first to be held in London – have announced the launch of the AI focussed iGB Affiliate Manager Academy which will be held July 1 as part of London ...
Department of Nephrology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China ...
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...
The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...
Step into the neon-lit streets of 1980s Miami with Detective Donut Kickback, the thrilling sequel slot where a pastry-loving cop is enjoying his final year of service. Drenched in a vibrant synth-wave ...
Step into the world of Zeus Cashpot and let the power of the Greek gods guide you to divine riches! Zeus Cashpot delivers an electrifying mix of strategy and chance, where every decision brings you ...
Reduction in Immunoglobulins: As expected with any B-cell depleting therapy, decreased immunoglobulin levels were observed. Decrease in immunoglobulin M (IgM) was reported in 0.6% of BRIUMVI-treated ...
Get all three sports-related questions of varying difficulty (easy, medium and hard) and you claim the Herald hat-trick. Want more quizzes? Test your knowledge in the Herald’s Morning quiz and ...
Inebilizumab significantly reduced the risk of treated and AC-determined IgG4-RD flare by 87% compared with placebo. The Food and Drug Administration (FDA) has approved Uplizna ® (inebilizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results